Scott Haake, MD, PhD(@DrScottHaake) 's Twitter Profileg
Scott Haake, MD, PhD

@DrScottHaake

Excited to learn more about kidney cancer, biomarkers, integrins, and ECM biology. Views expressed are my own, not any institution’s. RT/like not endorsement.

ID:2902661998

linkhttps://medsites.vumc.org/haakecancerlab calendar_today02-12-2014 18:05:52

254 Tweets

986 Followers

2,0K Following

Follow People
Scott Haake, MD, PhD(@DrScottHaake) 's Twitter Profile Photo

Thankful to ASMB and The University of Manchester for hosting this basement membrane workshop and allowing me to share my work. Received great feedback and learned a ton from the other attendees. Here is a nice video highlight. youtu.be/Fu5AkQ9JoRE?si…

account_circle
Scott Haake, MD, PhD(@DrScottHaake) 's Twitter Profile Photo

Thankful to ASMB and The University of Manchester for hosting this basement membrane workshop and allowing me to share my work. Received great feedback and learned a ton from the other attendees. Here is a nice video highlight. youtu.be/Fu5AkQ9JoRE?si…

account_circle
KidneyCAN(@kidneycan) 's Twitter Profile Photo

Many eyes are watching NCAA , but our eyes have been glued to . We are THRILLED to announce:

🎉 Victory for Research Funding!

🧵

Many eyes are watching NCAA #MarchMadness, but our eyes have been glued to #CapitolHill. We are THRILLED to announce: 🎉 Victory for #KidneyCancer Research Funding! 🧵
account_circle
Scott Haake, MD, PhD(@DrScottHaake) 's Twitter Profile Photo

I've been practicing medicine for what feels like a long time now and it is still sad when a patient passes away. We have good therapies in but still lots of room for improvement. We have work to do.

account_circle
Scott Haake, MD, PhD(@DrScottHaake) 's Twitter Profile Photo

For the first time, we have adjuvant therapy for clear cell with survival benefit. 38% decrease in risk of death after nephrectomy if treated w/ pembrolizumab. Congrats to investigators and patients/families. Big day for RCC community. Vanderbilt-Ingram Cancer Center Vanderbilt Hem / Onc

For the first time, we have adjuvant therapy for clear cell #RCC with survival benefit. 38% decrease in risk of death after nephrectomy if treated w/ pembrolizumab. Congrats to investigators and patients/families. Big day for RCC community. #kidneycancer @VUMC_Cancer @VUMCHemOnc
account_circle
Sumanta K. Pal, MD, FASCO(@montypal) 's Twitter Profile Photo

A well deserved spot for Tom Powles Barts Experimental Cancer Medicine Centre in nature's Top Ten of 2023. For those know him from the podium, a brilliant & who discovers, interprets & translates like no other. For those that know him personally, a friend who is always willing to take

A well deserved spot for @tompowles1 @BartsECMC in @Nature's Top Ten of 2023. For those know him from the podium, a brilliant #clinician & #scientist who discovers, interprets & translates like no other. For those that know him personally, a friend who is always willing to take
account_circle
Scott Haake, MD, PhD(@DrScottHaake) 's Twitter Profile Photo

Exciting to have FDA approval for belzutifan in sporadic ccRCC! I expect to be prescribing this soon for several patients.

fda.gov/drugs/resource…

account_circle
Scott Haake, MD, PhD(@DrScottHaake) 's Twitter Profile Photo

Thank you Dr. Tannir for your dedication to renal medullary carcinoma and for a beautiful and inspirational talk. Well deserved humanitarian award. You are a role model. Kidney Cancer MD Anderson Cancer Center

Thank you Dr. Tannir for your dedication to renal medullary carcinoma and for a beautiful and inspirational talk. Well deserved humanitarian award. You are a role model. @KidneyCancer @MDAndersonNews #ikcsna23
account_circle
Scott Haake, MD, PhD(@DrScottHaake) 's Twitter Profile Photo

Thanks Kathy! Joseph is awesome, wish I could have discussed his project in more depth. Come to and he can tell you all about it!

account_circle